Banner
WHAT'S NEW
please select
Another Breakthrough in Epidemic Prevention!(圖)
MEDIA
2021-12-10
Another Breakthrough in Epidemic Prevention! The Team at Kaohsiung Medical University Has Developed a COVID-19 Antibody Testing Platform for Precise Assessment of Antibody Efficacy
Fighting the Global Superbug Crisis: AMS BioteQ Develops Taiwan's First Local Antibiotic(圖)
MEDIA
2021-11-25
AMS BioteQ Chairman, Dr. Yi-Ju Tsai (center), and the team are actively conducting research to develop potential new drugs and address the unmet topical medication market.
Antibiotic-Resistant Superbug – one of the greatest threats to human health.
AMS BioteQ Expands Patent Layout, Aims to Lead in New Antibiotic Drug Research(圖)
MEDIA
2021-11-19
AMS BioteQ focuses its research and development efforts on three key stages: “novel compound development,” “patent in research and development technology,” and “new drug research and development.”
New Force of Novel Antimicrobial Dressings! AMS BioteQ Benefits Diabetic Wound Patients(圖)
MEDIA
2021-09-15
Dressings play a crucial role in accelerating wound healing.
Kaohsiung Native's Development of Oral COVID-19 Medication, AMS BioteQ Progressing by Year-End(圖)
MEDIA
2021-08-31
In the research and development of oral medication for Wuhan pneumonia (novel coronavirus disease, COVID-19), the Taiwanese biotechnology industry is actively involved.
The Good News in the Development of New Drugs for COVID-19!(圖)
MEDIA
2021-07-27
The Good News in the Development of New Drugs for COVID-19! A New Type of Antibiotic Has Shown Effective Virus Suppression
Good News About Antiviral Drugs: Local Antibiotic Shows Nearly 100% Effectiveness in Inhibiting the Coronavirus.(圖)
MEDIA
2021-07-22
As the COVID-19 pandemic subsides, there’s positive news regarding the first antibiotic developed by a Taiwanese biotech company to inhibit the coronavirus.
Fighting COVID-19! Taiwan's Self-developed Two New Drugs Inhibit Virus with Near-Perfect Performance(圖)
MEDIA
2021-04-14
As the global COVID-19 pandemic continues, despite ongoing vaccination efforts in various countries, many risks and concerns remain.